leisure time -WSS

leisure time

author：explore 2025-08-24 10:13:55 - browse：13218

Liver illustration — Hyacinth Empinado/STAT

SAN DIEGO — The American Diabetes Association said Sunday that all adults with type 2 diabetes or prediabetes should be screened for nonalcoholic fatty liver disease, an increasingly prevalent condition that can lead to serious liver damage.

There are no approved medications for the disease, but among available diabetes drugs, the ADA singled out GLP-1 treatments as an option doctors could consider, according to recommendations published during the annual ADA conference.

GLP-1 treatments, such as Ozempic and Mounjaro, are a class of drugs that have grown widely popular for their efficacy not only in lowering blood sugar, but also cutting weight. Drugmakers have started to study them in liver disease, and while some trials have shown they may offer some benefits, they haven’t yet been shown to improve harmful liver scarring.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Clinicians often fail to acknowledge the pain caused by long Covid

hotspot

WSS

Why Eli Lilly’s earnings didn’t quite live up to the hype

Achieving telehealth equity for people with hearing loss

The world needs the new pandemic treaty

Medical students need to learn the potent medicine of empathy

Congress might make insulin pumps more accessible to the blind

Report cites 'urgent' need to recruit more diverse clinical trial participants

entertainment

leisure time

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Unmasking the 'centricity' illusion in clinical trials

In Memoriam: Notable people who died in 2023

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Dobbs anniversary: the lost opportunity of abortion as health care

Some medical students still think black patients feel less pain

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The Bio Revolution is changing business and society

United colonoscopy coverage change 'may cost lives,' doctors say

The Bio Revolution is changing business and society

focus

Unmasking the 'centricity' illusion in clinical trials

Long Covid research funding gets a major boost from NIH

Bernie Sanders gets little from pharma CEOs on drug prices

Congress might make insulin pumps more accessible to the blind

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Pharma’s losing bet in New Jersey

hotspot

hotspot

hotspot

explore